1. Rollo J. Cases of Diabetes Mellitus. 2nd ed. Dilly, London, 1798, pp. 17-62.

2. Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Med 1998;15:508-514.

3. Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. N Engl J of Med 2004;351:48-55.

4. Pavy FW. Address on diabetes, Washington International Congress. Medical News, Philadelphia, 1887, p. 357.

5. Boulton AJM. The diabetic foot - from art to science. Diabetologia 2004;47:1343-1353.

6. Editorial. Diabetic neuropathy: where are we now? Lancet 1983;1366-1367.

7. Vinik AI, Mehrabyon A, Colen L, Boulton AJ. Focal entrapment neuropathies in diabetes. Diabetes Care 2004;27:1783-1788.

8. Boulton AJM, Malik RA, Arezzo JS, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-1486.

9. Archer AG, Watkins PJ, Thomas PK, et al. The natural history of acute Painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983;46:491-499.

10. Steel JM, Young RJ, Lloyd GG, Clarke BF. Clinical apparent eating disorders in young diabetic women: associations with painful neuropathies and other complications. Br Med J 1987;294:859-862.

11. Huskisson EC. Measurement of pain. Lancet 1974;ii:1127-1131.

12. Tandan R, Lewis GA, Krusinksi PB, et al. Topical Capsaicin in painful Neuropathy: controlled trial with long-term follow-up. Diabetes Care 1992;15:8-14.

13. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175-184.

14. Melzack R. The McGill Pain Questionnaire: major properties and scoring Methods. Pain 1975;1:277-299.

15. Masson EA, Hunt L, Gem JM, et al. A novel approach to the diagnosis and Assessment of symptomatic diabetic neuropthy. Pain 1989;38:25-28.

16. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:328-332.

17. Young MJ, Boulton AJM, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154.

18. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998;41:1263-1269.

19. Feldman EL, Stevens MJ, Thomas PK, et al. A practice two-step quantitative Clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1996;19:1881-1889.

20. Meijer JW, Smit AJ, Sondersen EV, et al. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom Score. Diabetes Med. 2002;19:962-965.

21. Benbow SJ, Wallymahmed ME, McFarlane IA. Diabetic peripheral Neuropathy and quality of life. QJM 1998;91:733-737.

22. Vileikyte L. Psychological aspects of diabetic peripheral neuropathy. Diabetes Reviews 1999;7: 387-394.

23. Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications. Diabetes Metab Res Rev 2004;20(Suppl 1):S13-S17.

24. Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy— and foot ulcer—specific quality of life instrument. Diabetes Care 2003;2549-2555.

25. Boulton AJM, Scarpello JHB, Armstrong WD, et al. The natural history of Painful diabetic neuropathy - a 4-year study. Postgrad Med J 1983;59:556-559.

26. Mendell JR, Sahenk Z. Painful sensory neuropathy. N Engl J Med 2003;348:1243-1255.

27. Dyck PJ, Katz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824.

28. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community controlled comparison of people with and without diabetes. Diabetic Med 2004;976-982.

29. Garrow AP, Silman AJ, MacFarlane GJ. The classification foot pain and disability survey: a population survey assessing prevalence and associations. Pain 2004;110:378-384.

30. DCCT Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Annals of Internal Med 1995;122:561-568.

31. Partanen J, Niskanen L, Lehtinen J, et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. N Engl J of Med 1995;333:39-84.

32. Tesfaye S, Stevens LK, Stephenson JM, EuroDiab IDDM study group. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risks: the EuroDiab IDDM complication study. Diabetologia 1996;39:1377-1386.

Oyibo S, Prasad YD, Jackson NJ, Jude EB, Boulton AJM. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabetic Med 2002;19:870-873.

Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001;24:1109-1112.

Boulton AJM, Drury J, Clarke B, Ward JD. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 1982;16:1446-1452. Boulton AJM, Levin S, Comstock JA. A multicentre trial of the aldose-Reductase inhibitor, tolrestat, in patients with symptomatic diabetic Neuropathy. Diabetologia 1990;33:431-437. Goto Y, Hotta N, Shigeta Y, et al. Effects of aldose-reductase inhibitor, Epalrestat, on diabetic neuropathy. Clinical benefit and indication for the Drug assessed from the results of a placebo-controlled double-blind study. Biomed Pharmacother 1995;49:269-277. Ziegler D, Reljanovic M. Mehnert H, et al. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes 1999;107:42-430.

Ametov AS, Barinov A, Dyck PJ, et al. SYDNEY Trial Study Group: the sensory symptoms of diabetic polyneuropathy are improved with a-lipoic acid: the SYDNEY trial. Diabetes Care 2003;26:770-776.

Vinik A, Tesfaye S, Hand D, Bastyr E. LY333531 treatment improves diabetic peripheral neuropathy with symptoms (Abstract). Diabetes 2002;51(Suppl 2):A79.

Boulton AJM, Vinik AJ, Arezzo JC, et al. Diabetic Neuropathies: a Statement by the

American Diabetes Association. Diabetes Care 2005;28:955-962.

Max MB, Lynch SA, Muir J, et al. Effects of despiramine, Amitriptyline and fluoxetine on pain relief in diabetic in diabetic neuropathy. N Engl J Med 1996;326:1250-1256.

McQuay H, Tramer M, Nye BA. A systematic review of antidepressants in neuropathic pain. Pain 1996;68:217-227.

Sindrup SH, Gram LF, Brosen K, et al. The SSRI Paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990;42:135-144.

Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor Citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;53:547-552. Rull JA, Quibrera R, Gonzalex-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with Carbamazepine (Tegretol): double blind crossover trial. Diabetologia 1969;5:215-218.

Backonja M, Beydoun A, Edward KR, et al. Gabapentin for the Symptomatic treatment of painful neuropathy in patients with diabetes Mellitus: a randomized controlled trial. JAMA 1998;280:1831-1836.

Backonja M, Glazman RL. Gabapentin dosing for neuropathic pain: evidence from randomized placebo controlled clinical trials. Clin Ther 2003;25:81-104. Rosenstock J, Tuchman M, LaMoreau L, et al. Pregabalin for the treatment of painful diabetic neuropathy: a randomized, controlled trial. Pain 2004;110:628-634. Beydoun A, Kobetz SA, Carrazana EJ. Efficacy of oxcarbazepine in the treatment of diabetic neuropathy. Clin J Pain 2004;20:174-178.

Kochar DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind trial. QJM 2004;97:33-38.

Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in Painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004;63:865-873. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1841-1846. Harati Y, Gooch C, Swenson M, Edelman SV, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Compl 2000;14:65-70.

55. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60:927-934.

56. Watson CPN, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003;105: 71-78.

57. Jarvis B, Coukell AJ. Mexilitene: a review of its therapeutic use in Painful diabetic neuropathy. Drugs 1998;56:691-708.

58. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48:1212-1218.

59. Kirby LC. Memantine in the treatment of diabetic patients with painful peripheral neuropathy: a double-blind placebo-controlled phase IIB trial. Pain Med 2002;3:182-183.

60. Zhang WY, Wan Po AL. The effectiveness of topically applied capsaicin: a meta-analysis. Eur J Clin Pharm 1994;45:517-522.

61. Low PA, Opfer-Gehrking TL, Dyck PJ, et al. Double-blind placebo- Controlled study of capsaicin cream in chronic distal painful Polyneuropathy. Pain 1995;62:163-168.

62. Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo- controlled cross-over study. Diabetes Care 2002;25:1699-1703.

63. Rayman G, Baker NR, Krishnan ST. Glyceryl trynitrate patches as an alternative to isosorbide dinitrate spray in the treatment of painful neuropathy. Diabetes Care 2003;26: 2697-2698.

64. Barbano RL, Herrmann DN, Hart SG, et al. Effectiveness, tolerability and impact on quality of life of the 5% Lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004;61: 914-918.

65. Kaye G, Wollitzer AO, Jovanovic L. Comfort and support improve painful diabetic neuropathy whereas disappointment and frustration deteriorate the metabolic and neuropathic status. Diabetes Care 2003;26:2478-2479.

66. Abusaisha BB, Constanzi JB, Boulton AJM. Acupuncture for the treatment of chronic painful diabetic neuropathy: a long-term study. Diabetes Res Clinl Practice 1998;39: 115-121.

67. Oyibo S, Breislin K, Boulton AJM. Electrical stimulation therapy through stocking electrodes for painful diabetic neuropathy: a double- blind controlled crossover study. Diabetic Med 2004;21:940-944.

68. Zinman LH, Ngo M, Ng ET, et al. Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial. Diabetes Care 2004;27:921-924.

69. Leonard DR, Farooqu MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized placebo-controlled study with monochromatic infrared treatment. Diabetes Care 2004; 27:168-172.

70. Hamza MA, White PF, Craig WF, et al. Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care 2000;23:365-370.

71. Weintraub MI, Wolfe GI, Barohn RA, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch of Phys Med Rehab 2003;86:736-746.

72. Tesfaye S, Watt J, Benbow SJ, et al. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696-1701.

73. Daousi C, Benbow SJ, Macfarlane IA. Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy. Diabet Med 2005;25:393-398.

Diabetes Sustenance

Diabetes Sustenance

Get All The Support And Guidance You Need To Be A Success At Dealing With Diabetes The Healthy Way. This Book Is One Of The Most Valuable Resources In The World When It Comes To Learning How Nutritional Supplements Can Control Sugar Levels.

Get My Free Ebook

Post a comment